Fenimore Christopher R. 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 10, 2024
Insider Transaction Report
Form 4
Fenimore Christopher R.
VP, Controller
Transactions
- Tax Payment
Common Stock
2024-12-09$787.00/sh−1,140$897,180→ 16,756 total - Award
Common Stock
2024-12-06+2,591→ 17,896 total - Award
Non-Qualified Stock Option (right to buy)
2024-12-06+9,979→ 9,979 totalExercise: $771.64Exp: 2034-12-06→ Common Stock (9,979 underlying)
Holdings
- 25(indirect: By Trust)
Common Stock
- 25(indirect: By Trust)
Common Stock
- 1,515(indirect: By 401(k))
Common Stock
- 1,897(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028.
- [F2]These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
- [F3]The stock option award vests in four equal annual installments, commencing one year after the date of grant.